|1.||Wang, Jie: 5 articles (04/2014 - 01/2007)|
|2.||Chen, Ke-ji: 3 articles (05/2013 - 04/2002)|
|3.||Xiong, Xingjiang: 2 articles (10/2015 - 04/2014)|
|4.||Yang, Xiaochen: 2 articles (04/2014 - 01/2013)|
|5.||Zhang, Jie: 2 articles (05/2006 - 03/2005)|
|6.||Wang, Pengqian: 1 article (10/2015)|
|7.||Li, Shengjie: 1 article (10/2015)|
|8.||Liu, Jian-xun: 1 article (06/2015)|
|9.||Li, Xin-zhi: 1 article (06/2015)|
|10.||Li, Hong-kun: 1 article (06/2015)|
01/01/2014 - "To evaluate the efficacy of Xuefu Zhuyu Tang (XFZYT) for treating angina pectoris (AP). "
01/01/2014 - "The usefulness of xuefu zhuyu tang for patients with angina pectoris: a meta-analysis and systematic review."
01/01/2007 - "[Evaluation on effects of disassembled formulas of Xuefu Zhuyu Decoction for treatment of angina pectoris using Seattle Angina Questionnaire]."
01/01/2007 - "To evaluate the therapeutic effect of disassembled formulas of Xuefu Zhuyu Decoction (XZD) for treatment of angina pectoris (AP) of coronary heart disease (CHD) using Seattle Angina Questionnaire (SAQ). "
|3.||Localized Scleroderma (Morphea)
03/01/2005 - "Follow-up efficacy of integrative Chinese and Western drugs on localized scleroderma with vitamine B6 and Xuefu Zhuyu decoction."
03/01/2005 - "To investigate the therapeutic effects of vitamine B(6) (Vit B(6)) and Xuefu Zhuyu Decoction (XFZY, for activating blood circulation to remove stasis) in patients with localized scleroderma(LSD). "
04/01/2014 - "Chinese patent medicine Xuefu Zhuyu capsule for the treatment of unstable angina pectoris: A systematic review of randomized controlled trials."
10/01/2010 - "Compared with Shengmai Capsule (生脉胶囊, SM), the study was conducted to evaluate the efficacy and safety of Xuefu Zhuyu Capsule (血府逐瘀胶囊, XFZY) on the symptoms and signs and health-related quality of life (HR-QOL) in the unstable angina (UA) patients with blood-stasis syndrome (BSS) after percutaneous coronary intervention (PCI). "
01/01/2013 - "We evaluated the effects of the Xuefu Zhuyu capsule (XFZY) and the Shengmai capsule (SM) on the evolution of syndromes and inflammatory markers in patients with unstable angina pectoris (UAP) after percutaneous coronary intervention (PCI). "
01/01/2013 - "The effects of xuefu zhuyu and shengmai on the evolution of syndromes and inflammatory markers in patients with unstable angina pectoris after percutaneous coronary intervention: a randomised controlled clinical trial."
10/01/2010 - "Effect of Xuefu Zhuyu Capsule (血府逐瘀胶囊) on the symptoms and signs and health-related quality of life in the unstable angina patients with blood-stasis syndrome after percutaneous coronary intervention: A Randomized controlled trial."
|5.||Coronary Disease (Coronary Heart Disease)
06/01/2015 - "There have been very few studies on the effect of Gualou Xiebai Banxia decoction combined with Xuefu Zhuyu decoction in inhibiting apoptosis in myocardial ischemial injury caused by coronary heart disease. "
06/01/2015 - "In conclusion, Gualou Xiebai Banxia decoction combined with Xuefu Zhuyu decoction have a significant protective effect against the myocardial apoptosis in miniature swine phlegm and blood stasis type coronary heart disease model."
06/01/2015 - "[Effect of Gualou Xiebai Banxia decoction combined with Xuefu Zhuyu decoction on myocardial apoptosis and relevant protein expressions in miniature swine phlegm and blood stasis type coronary heart disease model]."
11/01/2008 - "Xuefu Zhuyu Oral Liquid can improve clinical symptoms and hemorheology in the patients with blood-stasis syndrome due to coronary heart disease, which is related to GPIIb HPA-3 polymorphism."
11/01/2008 - "[Effects of Xuefu Zhuyu Oral Liquid on hemorheology in patients with blood-stasis syndrome due to coronary disease and their relationship with human platelet antigen-3 polymorphism]."
|2.||Caspase 3 (Caspase-3)
|3.||Platelet Membrane Glycoprotein IIb
|4.||Endothelin-1 (Endothelin 1)
|5.||Nitric Oxide Synthase (NO Synthase)
|7.||Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
|8.||Tissue Plasminogen Activator (Alteplase)
|9.||Nitric Oxide (Nitrogen Monoxide)
|10.||Lysergic Acid Diethylamide (LSD)
|3.||Chinese Traditional Medicine (Traditional Chinese Medicine)
|4.||Enteral Nutrition (Feeding, Tube)